Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1155133

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1155133

Asia Pacific Cellular Health Screening Market Size, Share & Industry Trends Analysis Report By Sample Type, By Collection Site, By Test Type, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 86 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Asia Pacific Cellular Health Screening Market would witness market growth of 9.7% CAGR during the forecast period (2022-2028).

The use of cellular health screening is growing in personalized medicine. Numerous studies have demonstrated a relationship between telomere length and malignancies. In cancer that has advanced more severely, telomere shortening as a tumor suppressor emerges to be a key impact. Telomere length is influenced by a variety of factors, including inflammations, infections, and stress. Inflammation, in particular, induces oxidative stress, which leads to telomere erosion.

According to studies, telomere maintenance has a substantial impact on how environmental, behavioral, and genetic variables influence aging and related illnesses. To comprehend biological aging and genetic diseases, it is necessary to grasp how quickly telomeres change. In addition, disorders connected to aging, such as cancer, cardiovascular diseases, and compromised immune systems, have been related to telomere length decrease.

The development of telomere testing kits has proved to be a significant innovation aiding in the early diagnosis of cancers. A growing insistence on healthy life expectancy and an increment in the public's average age, accompanied by a rise in the acceptance of digital testing technologies has resulted in healthcare facilities to opt testing methods that are quick and accurate. Also, the likelihood of spotting a condition may increase if multiple tests respond to a single medical issue.

In the above middle Asia-Pacific nations and territories, lung, trachea, and bronchus cancer were the most common cancer types in 2016. In lower-middle and lower-income Asia-Pacific nations and territories, liver cancer was the leading cause of cancer fatalities in 2016. Stomach, colorectal, and breast cancer were other leading causes of cancer-related mortality. These deaths were associated with Helicobacter pylori infection and were more common in Mongolia, China, the Republic of Korea, Japan, and Vietnam. Deaths from colorectal cancer were greater in Singapore, New Zealand, and Brunei Darussalam.

The China market dominated the Asia Pacific Cellular Health Screening Market by Country in 2021; thereby, achieving a market value of $354.8 million by 2028. The Japan market would showcase a CAGR of 8.9% during (2022 - 2028). Additionally, The India market is estimated to grow a CAGR of 10.4% during (2022 - 2028).

Based on Sample Type, the market is segmented into Blood, Saliva, Serum, and Urine. Based on Collection Site, the market is segmented into Hospital, Diagnostic Labs, Home, and Office. Based on Test Type, the market is segmented into Single Test Panels and Multi-test Panels. Based on Single Test Panels Type, the market is segmented into Oxidative Stress Tests, Inflammation Tests, Telomere Tests, and Heavy Metals Tests. The report also covers geographical segmentation of Cellular Health Screening market. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.

Scope of the Study

Market Segments covered in the Report:

By Sample Type

  • Blood
  • Saliva
  • Serum
  • Urine

By Collection Site

  • Hospital
  • Diagnostic Labs
  • Home
  • Office

By Test Type

  • Single Test Panels
    • Oxidative Stress Tests
    • Inflammation Tests
    • Telomere Tests
    • Heavy Metals Tests
  • Multi-test Panels

By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Quest Diagnostics Incorporated
  • OPKO Health, Inc.
  • Laboratory Corporation of America Holdings
  • Genova Diagnostics
  • Telomere Diagnostics, Inc.
  • Life Length, S.L.
  • Repeat Diagnostics, Inc.
  • SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
  • Cell Science Systems Corp.
  • Segterra, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Cellular Health Screening Market, by Sample Type
    • 1.4.2 Asia Pacific Cellular Health Screening Market, by Collection Site
    • 1.4.3 Asia Pacific Cellular Health Screening Market, by Test Type
    • 1.4.4 Asia Pacific Cellular Health Screening Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Asia Pacific Cellular Health Screening Market by Sample Type

  • 3.1 Asia Pacific Blood Market by Country
  • 3.2 Asia Pacific Saliva Market by Country
  • 3.3 Asia Pacific Serum Market by Country
  • 3.4 Asia Pacific Urine Market by Country

Chapter 4. Asia Pacific Cellular Health Screening Market by Collection Site

  • 4.1 Asia Pacific Hospital Market by Country
  • 4.2 Asia Pacific Diagnostic Labs Market by Country
  • 4.3 Asia Pacific Home Market by Country
  • 4.4 Asia Pacific Office Market by Country

Chapter 5. Asia Pacific Cellular Health Screening Market by Test Type

  • 5.1 Asia Pacific Single Test Panels Market by Country
  • 5.2 Asia Pacific Cellular Health Screening Market by Single Test Panels Type
    • 5.2.1 Asia Pacific Oxidative Stress Tests Market by Country
    • 5.2.2 Asia Pacific Inflammation Tests Market by Country
    • 5.2.3 Asia Pacific Telomere Tests Market by Country
    • 5.2.4 Asia Pacific Heavy Metals Tests Market by Country
  • 5.3 Asia Pacific Multi-test Panels Market by Country

Chapter 6. Asia Pacific Cellular Health Screening Market by Country

  • 6.1 China Cellular Health Screening Market
    • 6.1.1 China Cellular Health Screening Market by Sample Type
    • 6.1.2 China Cellular Health Screening Market by Collection Site
    • 6.1.3 China Cellular Health Screening Market by Test Type
      • 6.1.3.1 China Cellular Health Screening Market by Single Test Panels Type
  • 6.2 Japan Cellular Health Screening Market
    • 6.2.1 Japan Cellular Health Screening Market by Sample Type
    • 6.2.2 Japan Cellular Health Screening Market by Collection Site
    • 6.2.3 Japan Cellular Health Screening Market by Test Type
      • 6.2.3.1 Japan Cellular Health Screening Market by Single Test Panels Type
  • 6.3 India Cellular Health Screening Market
    • 6.3.1 India Cellular Health Screening Market by Sample Type
    • 6.3.2 India Cellular Health Screening Market by Collection Site
    • 6.3.3 India Cellular Health Screening Market by Test Type
      • 6.3.3.1 India Cellular Health Screening Market by Single Test Panels Type
  • 6.4 Australia Cellular Health Screening Market
    • 6.4.1 Australia Cellular Health Screening Market by Sample Type
    • 6.4.2 Australia Cellular Health Screening Market by Collection Site
    • 6.4.3 Australia Cellular Health Screening Market by Test Type
      • 6.4.3.1 Australia Cellular Health Screening Market by Single Test Panels Type
  • 6.5 South Korea Cellular Health Screening Market
    • 6.5.1 South Korea Cellular Health Screening Market by Sample Type
    • 6.5.2 South Korea Cellular Health Screening Market by Collection Site
    • 6.5.3 South Korea Cellular Health Screening Market by Test Type
      • 6.5.3.1 South Korea Cellular Health Screening Market by Single Test Panels Type
  • 6.6 Malaysia Cellular Health Screening Market
    • 6.6.1 Malaysia Cellular Health Screening Market by Sample Type
    • 6.6.2 Malaysia Cellular Health Screening Market by Collection Site
    • 6.6.3 Malaysia Cellular Health Screening Market by Test Type
      • 6.6.3.1 Malaysia Cellular Health Screening Market by Single Test Panels Type
  • 6.7 Rest of Asia Pacific Cellular Health Screening Market
    • 6.7.1 Rest of Asia Pacific Cellular Health Screening Market by Sample Type
    • 6.7.2 Rest of Asia Pacific Cellular Health Screening Market by Collection Site
    • 6.7.3 Rest of Asia Pacific Cellular Health Screening Market by Test Type
      • 6.7.3.1 Rest of Asia Pacific Cellular Health Screening Market by Single Test Panels Type

Chapter 7. Company Profiles

  • 7.1 Quest Diagnostics Incorporated
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental Analysis
    • 7.1.4 Recent strategies and developments:
      • 7.1.4.1 Partnerships, Collaborations, and Agreements:
      • 7.1.4.2 Product Launches and Product Expansions:
  • 7.2 OPKO Health, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Laboratory Corporation of America Holdings
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental Analysis
  • 7.4 Genova Diagnostics
    • 7.4.1 Company Overview
    • 7.4.2 Recent strategies and developments:
      • 7.4.2.1 Partnerships, Collaborations, and Agreements:
  • 7.5 Telomere Diagnostics, Inc.
    • 7.5.1 Company Overview
  • 7.6 Life Length, S.L.
    • 7.6.1 Company Overview
  • 7.7 Repeat Diagnostics, Inc.
    • 7.7.1 Company Overview
  • 7.8 SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
    • 7.8.1 Company Overview
  • 7.9 Cell Science Systems Corp.
    • 7.9.1 Company Overview
  • 7.10. Segterra, Inc. (INSIDETRACKER)
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Asia Pacific Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 2 Asia Pacific Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 3 Asia Pacific Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 4 Asia Pacific Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 5 Asia Pacific Blood Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Asia Pacific Blood Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Asia Pacific Saliva Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Asia Pacific Saliva Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Asia Pacific Serum Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Asia Pacific Serum Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Asia Pacific Urine Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Asia Pacific Urine Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Asia Pacific Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 14 Asia Pacific Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 15 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Asia Pacific Diagnostic Labs Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Asia Pacific Diagnostic Labs Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Asia Pacific Home Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Asia Pacific Home Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Asia Pacific Office Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Asia Pacific Office Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Asia Pacific Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 24 Asia Pacific Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 25 Asia Pacific Single Test Panels Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Asia Pacific Single Test Panels Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 28 Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 29 Asia Pacific Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 30 Asia Pacific Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 31 Asia Pacific Inflammation Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Asia Pacific Inflammation Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Asia Pacific Telomere Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 34 Asia Pacific Telomere Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 35 Asia Pacific Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Asia Pacific Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Asia Pacific Multi-test Panels Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Asia Pacific Multi-test Panels Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Asia Pacific Cellular Health Screening Market by Country, 2018 - 2021, USD Million
  • TABLE 40 Asia Pacific Cellular Health Screening Market by Country, 2022 - 2028, USD Million
  • TABLE 41 China Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 42 China Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 43 China Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 44 China Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 45 China Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 46 China Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 47 China Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 48 China Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 49 China Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 50 China Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 51 Japan Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 52 Japan Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 53 Japan Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 54 Japan Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 55 Japan Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 56 Japan Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 57 Japan Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 58 Japan Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 59 Japan Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 60 Japan Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 61 India Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 62 India Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 63 India Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 64 India Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 65 India Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 66 India Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 67 India Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 68 India Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 69 India Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 70 India Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 71 Australia Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 72 Australia Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 73 Australia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 74 Australia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 75 Australia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 76 Australia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 77 Australia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 78 Australia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 79 Australia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 80 Australia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 81 South Korea Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 82 South Korea Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 83 South Korea Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 84 South Korea Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 85 South Korea Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 86 South Korea Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 87 South Korea Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 88 South Korea Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 89 South Korea Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 90 South Korea Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 91 Malaysia Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 92 Malaysia Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 93 Malaysia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 94 Malaysia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 95 Malaysia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 96 Malaysia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 97 Malaysia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 98 Malaysia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 99 Malaysia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 100 Malaysia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 101 Rest of Asia Pacific Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 102 Rest of Asia Pacific Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 103 Rest of Asia Pacific Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 104 Rest of Asia Pacific Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 105 Rest of Asia Pacific Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 106 Rest of Asia Pacific Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 107 Rest of Asia Pacific Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 108 Rest of Asia Pacific Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 109 Rest of Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 110 Rest of Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 111 Key information - Quest Diagnostics Incorporated
  • TABLE 112 Key Information - OPKO Health, Inc.
  • TABLE 113 Key Information - Laboratory Corporation of America holdings
  • TABLE 114 Key Information - Genova Diagnostics
  • TABLE 115 Key Information - Telomere Diagnostics, Inc.
  • TABLE 116 Key Information - LIFE LENGTH, S.L.
  • TABLE 117 Key Information - Repeat Diagnostics, Inc.
  • TABLE 118 Key Information - SpectraCell Laboratories, Inc.
  • TABLE 119 Key Information - Cell Science Systems Corp.
  • TABLE 120 Key Information - SEGTERRA (INSIDETRACKER)

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Quest Diagnostics Incorporated
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!